MX2012007234A - Nanocristales de monohidrato de calciprotiol. - Google Patents
Nanocristales de monohidrato de calciprotiol.Info
- Publication number
- MX2012007234A MX2012007234A MX2012007234A MX2012007234A MX2012007234A MX 2012007234 A MX2012007234 A MX 2012007234A MX 2012007234 A MX2012007234 A MX 2012007234A MX 2012007234 A MX2012007234 A MX 2012007234A MX 2012007234 A MX2012007234 A MX 2012007234A
- Authority
- MX
- Mexico
- Prior art keywords
- calcipotriol monohydrate
- monohydrate nanocrystals
- nanocrystals
- calcipotriol
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/21—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a non-condensed ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describen los nanocristales de monohidrato de calcipotriol preparados mediante el proceso de la presente, que pueden ser incorporados en una composición farmacéutica para el uso en la prevención o tratamiento de trastornos y condiciones dérmicas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK2009000267 | 2009-12-22 | ||
US29309110P | 2010-01-07 | 2010-01-07 | |
PCT/DK2010/000183 WO2011076208A2 (en) | 2009-12-22 | 2010-12-22 | Calcipotriol monohydrate nanocrystals |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2012007234A true MX2012007234A (es) | 2012-07-30 |
Family
ID=43618145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012007234A MX2012007234A (es) | 2009-12-22 | 2010-12-22 | Nanocristales de monohidrato de calciprotiol. |
Country Status (16)
Country | Link |
---|---|
US (2) | US20130039952A1 (es) |
EP (1) | EP2515874B1 (es) |
JP (1) | JP5816194B2 (es) |
CN (1) | CN102770125B (es) |
AU (1) | AU2010335655B2 (es) |
BR (1) | BR112012015449B1 (es) |
CA (1) | CA2785253A1 (es) |
ES (1) | ES2523119T3 (es) |
HK (1) | HK1177694A1 (es) |
IL (1) | IL220516A (es) |
MX (1) | MX2012007234A (es) |
NZ (1) | NZ601000A (es) |
PL (1) | PL2515874T3 (es) |
RU (1) | RU2555339C2 (es) |
WO (1) | WO2011076208A2 (es) |
ZA (1) | ZA201204618B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6491658B2 (ja) * | 2013-07-18 | 2019-03-27 | マンカインド コーポレイション | 熱安定性乾燥粉末医薬組成物及び方法 |
CN105534996B (zh) * | 2016-02-24 | 2018-05-01 | 长沙佰顺生物科技有限公司 | 一种治疗银屑病的药物组合物 |
BR112019000112A2 (pt) | 2016-07-05 | 2019-04-09 | Kratos LLC | partículas do grupo iva micrônicas e sub-micrônicas pré-litiadas passivadas e métodos de preparação das mesmas |
WO2018183909A1 (en) * | 2017-03-31 | 2018-10-04 | Kratos LLC | Precharged negative electrode material for secondary battery |
CN108904445A (zh) * | 2018-08-06 | 2018-11-30 | 江苏知原药业有限公司 | 钙泊三醇纳米悬浮液 |
CN109157661B (zh) * | 2018-09-10 | 2021-09-24 | 南京工业大学 | 一种配体辅助下用氧化物silica包覆疏水性分子晶体的方法 |
RU2749360C1 (ru) * | 2020-10-09 | 2021-06-09 | Федеральное государственное бюджетное военное образовательное учреждение высшего образования "Военно-медицинская академия имени С.М. Кирова" Министерства обороны Российской Федерации (ВМедА) | Способ лечения ладонно-подошвенного пустулеза |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8315787D0 (en) * | 1983-06-08 | 1983-07-13 | Briggs J H | Coolant spray |
US4758432A (en) * | 1984-10-15 | 1988-07-19 | Richardson-Vicks Inc. | Topical treatment of skin inflammatory disorders |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
GB9300763D0 (en) * | 1993-01-15 | 1993-03-03 | Leo Pharm Prod Ltd | Chemical compound |
DE4440337A1 (de) * | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
GB9504265D0 (en) * | 1995-03-03 | 1995-04-19 | Medeva Plc | Corticosteroid-containing pharmaceutical composition |
US8263580B2 (en) * | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
DE19932157A1 (de) | 1999-07-13 | 2001-01-18 | Pharmasol Gmbh | Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln |
US6403654B1 (en) * | 2000-04-13 | 2002-06-11 | Mariana De Oliveira | Compositions for and method of treatment for psoriasis |
DK1331927T3 (da) * | 2000-10-27 | 2008-05-05 | Leo Pharma As | Topisk komposition der indeholder mindst et D-vitamin eller en D-vitamin analog og mindst et kosttikosteroid |
CA2436574A1 (en) * | 2000-12-06 | 2002-06-13 | Pharmacia Corporation | Laboratory scale milling process |
FR2834212B1 (fr) * | 2001-12-27 | 2004-07-09 | Besins Int Belgique | Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques |
AU2002356294A1 (en) | 2002-12-13 | 2004-07-09 | Jagotec Ag | A topical nanoparticulate spironolactone formulation |
DK1658263T3 (da) | 2003-07-24 | 2010-09-27 | Leo Pharma As | Aminobenzophenonforbindelser |
WO2005107710A2 (en) * | 2004-05-06 | 2005-11-17 | Ivrea Pharmaceuticals, Inc. | Particles for the delivery of active agents |
US20060110415A1 (en) * | 2004-11-22 | 2006-05-25 | Bioderm Research | Topical Delivery System for Cosmetic and Pharmaceutical Agents |
ATE455768T1 (de) | 2004-12-13 | 2010-02-15 | Leo Pharma As | Triazolsubstituierte aminobenzophenonverbindungen |
JP5612263B2 (ja) * | 2005-06-01 | 2014-10-22 | スティーフェル リサーチ オーストラリア ピーティーワイ リミテッド | ビタミン製剤 |
US20070154402A1 (en) * | 2005-10-24 | 2007-07-05 | Collegium Pharmaceutical, Inc. | Topical Pharmaceutical Foam Composition |
AU2007264418B2 (en) * | 2006-06-30 | 2012-05-03 | Iceutica Pty Ltd | Methods for the preparation of biologically active compounds in nanoparticulate form |
CA2669392C (en) * | 2006-11-17 | 2016-05-10 | Abbott Gmbh & Co. Kg | Nanocrystals for use in topical cosmetic formulations and method of production thereof |
AU2007336538B2 (en) | 2006-12-22 | 2012-04-05 | Leo Pharma A/S | Substituted acetophenones useful as PDE4 inhibitors |
JP5501770B2 (ja) | 2007-02-28 | 2014-05-28 | レオ ファーマ アクティーゼルスカブ | 新規ホスホジエステラーゼ阻害剤 |
WO2008128538A1 (en) | 2007-04-19 | 2008-10-30 | Leo Pharma A/S | Src family kinase inhibitors |
US20100189674A1 (en) | 2007-05-11 | 2010-07-29 | Sonneborn Inc. | Petrolatum Having Silicone-Like Properties |
MX2011006428A (es) | 2008-12-19 | 2011-07-28 | Leo Pharma As | Triazolopiridinas como inhibidores de fosfodiesterasa para tratamiento de enfermedades dermicas. |
-
2010
- 2010-12-22 CA CA2785253A patent/CA2785253A1/en not_active Abandoned
- 2010-12-22 RU RU2012130412/15A patent/RU2555339C2/ru active
- 2010-12-22 CN CN201080064526.6A patent/CN102770125B/zh active Active
- 2010-12-22 BR BR112012015449-4A patent/BR112012015449B1/pt active IP Right Grant
- 2010-12-22 JP JP2012545091A patent/JP5816194B2/ja active Active
- 2010-12-22 EP EP10803440.6A patent/EP2515874B1/en active Active
- 2010-12-22 US US13/518,214 patent/US20130039952A1/en not_active Abandoned
- 2010-12-22 ES ES10803440.6T patent/ES2523119T3/es active Active
- 2010-12-22 MX MX2012007234A patent/MX2012007234A/es active IP Right Grant
- 2010-12-22 AU AU2010335655A patent/AU2010335655B2/en active Active
- 2010-12-22 PL PL10803440T patent/PL2515874T3/pl unknown
- 2010-12-22 WO PCT/DK2010/000183 patent/WO2011076208A2/en active Application Filing
- 2010-12-22 NZ NZ601000A patent/NZ601000A/en unknown
-
2012
- 2012-06-19 IL IL220516A patent/IL220516A/en active IP Right Grant
- 2012-06-21 ZA ZA2012/04618A patent/ZA201204618B/en unknown
-
2013
- 2013-04-23 HK HK13104896.2A patent/HK1177694A1/xx unknown
-
2014
- 2014-03-20 US US14/220,843 patent/US20140322331A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2515874B1 (en) | 2014-08-20 |
US20140322331A1 (en) | 2014-10-30 |
IL220516A (en) | 2015-06-30 |
US20130039952A1 (en) | 2013-02-14 |
RU2555339C2 (ru) | 2015-07-10 |
EP2515874A2 (en) | 2012-10-31 |
CN102770125A (zh) | 2012-11-07 |
PL2515874T3 (pl) | 2015-01-30 |
BR112012015449B1 (pt) | 2021-09-28 |
AU2010335655B2 (en) | 2015-03-05 |
NZ601000A (en) | 2014-07-25 |
JP2013515019A (ja) | 2013-05-02 |
CA2785253A1 (en) | 2011-06-30 |
AU2010335655A1 (en) | 2012-07-19 |
WO2011076208A3 (en) | 2012-03-01 |
ES2523119T3 (es) | 2014-11-21 |
RU2012130412A (ru) | 2014-01-27 |
BR112012015449A2 (pt) | 2016-03-15 |
JP5816194B2 (ja) | 2015-11-18 |
HK1177694A1 (en) | 2013-08-30 |
CN102770125B (zh) | 2015-02-11 |
ZA201204618B (en) | 2013-09-25 |
WO2011076208A2 (en) | 2011-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201304638B (en) | Composition for use in the prevention and /or treatment of skin condition and skin diseases. | |
IL207546A0 (en) | Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases | |
UA108198C2 (uk) | Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування | |
IL206080A0 (en) | Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases | |
MX2012007234A (es) | Nanocristales de monohidrato de calciprotiol. | |
TN2011000370A1 (en) | Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof | |
MX2009010407A (es) | Derivados fluorados de deferiprona. | |
IN2012DN00971A (es) | ||
MY152279A (en) | Immediate release pharmaceutical compositions comprising oxycodone and naloxone | |
IL216967B (en) | The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases | |
PL2429515T3 (pl) | Nowe leki do stosowania miejscowego oparte na siarczanowanym kwasie hialuronowym jako środku aktywującym lub inhibitującym aktywność cytokin | |
ZA201200944B (en) | Pharmaceutical compositions for the treatment of cancer and other diseases or disorders | |
ZA201203281B (en) | Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals | |
GB2497453B8 (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV | |
PH12012501389A1 (en) | Hedgehog inhibitors | |
EP2296665A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PREMATURE EJACULATION | |
PL2640364T3 (pl) | Kompozycja farmaceutyczna zawierająca sól wodorowęglanową i jej zastosowanie jako leku w leczeniu i/lub profilaktyce kamicy moczowej i chorób pokrewnych | |
WO2011113000A8 (en) | Novel ester containing compositions and methods | |
MX366496B (es) | Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso. | |
EP2480099A4 (en) | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING METABOLIC DISEASES | |
HK1172568A1 (en) | Soluble pharmaceutical forms of n,n-diaminodiphenyl sulphone for optimum use in the treatment of various diseases nn- | |
WO2010149658A3 (en) | Pharmaceutical composition comprising gamma - butyrobetaine and meldonium | |
UA56130U (ru) | Способ лечения и профилактики телязиоза | |
WO2011075605A3 (en) | Hyperglycosylated interferon variants and methods of use | |
HU0800083D0 (en) | Pharmaceutical compositions for the treatment and prevention of tumorous diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |